|
|
|
News Release
Seattle, WA, April, 2011 - MRI of vessel wall for plaque characterization has recently been included in American College of Radiology (ACR) Appropriateness Criteria for MRA neck procedures.
Seattle, WA, February, 2011 - University of Washington Center for Commercialization has featured VPDiagnostics’ commercialization effort in its annual report. See link for details.
Seattle, WA, September, 2010 - The Agency for Healthcare Research and Quality (AHRQ) of U.S. Department of Health and Human Services (HHS) issued Technical Brief, entitled “Vulnerable Atherosclerotic Plaque”. The brief provides an overview of vulnerable plaque, a long list of references, discussion, and a list of commercial products that are in the space of diagnosing and treating plaques. MRI-PlaqueViewTM is listed on page 60.
Seattle, WA, June, 2010 - Philips Healthcare and VPDiagnostics, Inc. have signed a co-marketing agreement. Under this agreement, VPDiagnostics will provide its FDA 510 (k) cleared carotid artery atherosclerosis analysis package, called MRI-PlaqueViewTM, for Philips MRI customers. Click product offering for product details. Click more for news details.
Seattle, WA, April, 2010 - VPDiagnostics, Inc. announces the release of plaque analysis software: MRI-PlaqueViewTM 2.0. VPDiagnostics is also actively recruiting clinical sites for an NIH-sponsored multi-center prospectiveclinical trial. more...
Seattle, WA, February, 2010 - The result of Carotid Revascularization Endartectomy vs. Stenting Trial (CREST) has just been published on NEJM. The result of the International Carotid Stenting Study (ICSS) has just been published on Lancet
.
Seattle, WA, May, 2009 - VPDiagnostics, Inc. announces that MRI-PlaqueViewTM has been selected as the analysis software for carotid and aorta MRI data in the High-Risk Plaque (HRP) study. The analysis conducted by the University of Washington and Mount Sinai Medical Center has been successfully executed by May 2009.
Seattle, WA, March, 2009 - VPDiagnostics, Inc. announces its new product, MRI-PlaqueViewTM. VPDiagnostics also announces the start of a multi-center clinical trial sponsored by the NIH. more...
Seattle, WA, April, 2007 - VPDiagnostics, Inc. announced the receipt of a NIH SBIR phase II grant over 3 years. The new funding will be used to complete the commercialization of technology for vessel wall image analysis, with a focus on obtaining regulatory approval for their software.
Seattle, WA, May, 2006 - University of Washington TechTransfer announced today it has licensed a computer-aided cardiovascular analysis system to VPDiagnostics, a Washington state firm.
| |
|
|